{"id":"https://openalex.org/W2010198608","doi":"https://doi.org/10.1097/00004850-199709000-00001","title":"Social phobia: long-term treatment outcome and prediction of response - a moclobemide study","display_name":"Social phobia: long-term treatment outcome and prediction of response - a moclobemide study","alternate_titles":[],"publication_year":1997,"publication_date":"1997-09-01","ids":{"openalex":"https://openalex.org/W2010198608","doi":"https://doi.org/10.1097/00004850-199709000-00001","mag":"2010198608","pmid":"https://pubmed.ncbi.nlm.nih.gov/9466158"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-199709000-00001","doi":"https://doi.org/10.1097/00004850-199709000-00001","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199709000-00001","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2010198608"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109113043","display_name":"M\u00e1rcio Versiani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Versiani","raw_affiliation_strings":["Department of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040072237","display_name":"R. Amrein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Amrein","raw_affiliation_strings":["F. Hoffmann-La Roche, Pharma Business Development and Strategic Marketing, Grenzacherstrasse, 4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche, Pharma Business Development and Strategic Marketing, Grenzacherstrasse, 4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002162783","display_name":"Stuart Montgomery","orcid":"https://orcid.org/0000-0002-5983-0063","observed_orcids":["https://orcid.org/0000-0002-5983-0063"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. A. Montgomery","raw_affiliation_strings":["Imperial College of Medicine, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial College of Medicine, London, UK","institution_ids":["https://openalex.org/I47508984"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8468,"has_fulltext":false,"cited_by_count":49,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.82680723,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"12","issue":"5","first_page":"239","last_page":"254"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/social-anxiety-disorder","display_name":"social anxiety disorder","score":0.9980000257492065},{"id":"https://openalex.org/keywords/moclobemide","display_name":"moclobemide","score":0.9800000190734863},{"id":"https://openalex.org/keywords/long-term-treatment","display_name":"long-term treatment","score":0.7229999899864197},{"id":"https://openalex.org/keywords/treatment-outcome-predictors","display_name":"treatment outcome predictors","score":0.5809999704360962},{"id":"https://openalex.org/keywords/alcohol-abuse","display_name":"alcohol abuse","score":0.8209999799728394},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.5139999985694885},{"id":"https://openalex.org/keywords/generalized-anxiety-disorder","display_name":"generalized anxiety disorder","score":0.7160000205039978},{"id":"https://openalex.org/keywords/dysthymia","display_name":"dysthymia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/avoidant-personality-disorder","display_name":"avoidant personality disorder","score":0.8029999732971191},{"id":"https://openalex.org/keywords/trazodone","display_name":"trazodone","score":0.5189999938011169}],"concepts":[{"id":"https://openalex.org/C2780237459","wikidata":"https://www.wikidata.org/wiki/Q421934","display_name":"Moclobemide","level":4,"score":0.7952813506126404},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.788784384727478},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.521074652671814},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4852995276451111},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.4552854001522064},{"id":"https://openalex.org/C2776317618","wikidata":"https://www.wikidata.org/wiki/Q544006","display_name":"Anxiety disorder","level":3,"score":0.43816015124320984},{"id":"https://openalex.org/C2777545354","wikidata":"https://www.wikidata.org/wiki/Q3557657","display_name":"Social anxiety","level":3,"score":0.42926114797592163},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3932512402534485},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.353230357170105},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.17290380597114563},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.11747458577156067},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010698","descriptor_name":"Phobic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020912","descriptor_name":"Moclobemide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004850-199709000-00001","doi":"https://doi.org/10.1097/00004850-199709000-00001","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199709000-00001","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:9466158","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9466158","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2001168479","https://openalex.org/W1995326253","https://openalex.org/W2132709127","https://openalex.org/W2170551345","https://openalex.org/W1994949844","https://openalex.org/W17908275","https://openalex.org/W2328513577","https://openalex.org/W7100344442","https://openalex.org/W2914757727"],"abstract_inverted_index":{"In":[0,89,261],"this":[1,233],"open,":[2],"prospective,":[3],"structured,":[4],"naturalistic":[5],"study":[6,119,135],"of":[7,10,38,69,77,85,111,117,140,209,220,257],"the":[8,86,112,115,118,121,217,271],"efficacy":[9],"long-term":[11,272],"treatment":[12,44,93,191,298],"in":[13,107,169,207,232,270],"social":[14,25,185,245,248,264],"phobia":[15,26,186,249,265],"93":[16],"consecutive":[17],"outpatients":[18],"suffering":[19],"from":[20],"severe":[21,184,263],"generalized":[22,224],"or":[23,145,183,196,240,247,279],"circumscribed":[24,244],"(median":[27],"Liebowitz":[28],"Social":[29],"Anxiety":[30],"Scale":[31],"score":[32],"83)":[33],"and":[34,125,166,176,187,227],"a":[35,74,90,108,258],"high":[36,236],"degree":[37],"concomitant":[39],"psychiatric":[40],"disease":[41],"were":[42,142,151,156,161,168,188,229,255],"administered":[43],"with":[45,95,251],"moclobemide":[46,96,175],"(712":[47],"+/-":[48],"75":[49],"mg/day":[50],"at":[51,78,114,131],"steady":[52],"state).":[53],"Fifty-nine":[54],"patients":[55,87,98,113,141,275],"who":[56,99],"responded":[57],"(Clinical":[58],"Global":[59],"Impression":[60],"for":[61,281],"Change:":[62],"very":[63],"much/much":[64],"improved)":[65],"completed":[66],"2":[67],"years":[68],"treatment.":[70],"Patients":[71],"then":[72,126],"entered":[73],"drug-free":[75],"period":[76,94],"least":[79],"1":[80],"month":[81],"during":[82],"which":[83],"88%":[84],"deteriorated.":[88],"further":[91],"2-year":[92],"those":[97],"had":[100,146,181],"deteriorated":[101],"became":[102],"responders":[103],"again.":[104],"Symptoms":[105],"recurred":[106],"substantial":[109],"number":[110],"end":[116],"when":[120],"dose":[122],"was":[123,214],"reduced":[124],"discontinued.":[127],"Post-study":[128],"follow":[129],"up":[130],"6-24":[132],"months":[133],"after":[134],"completion":[136],"found":[137],"that":[138],"63.2%":[139],"almost":[143],"asymptomatic":[144],"only":[147],"mild":[148],"symptoms,":[149],"15.8%":[150],"off":[152,189],"all":[153,190,210],"treatment,":[154],"28.1%":[155],"back":[157],"on":[158,193,197],"moclobemide,":[159],"10.6%":[160],"taking":[162],"another":[163,198],"psychotropic":[164,199],"drug":[165,200],"8.8%":[167],"psychotherapy.":[170],"All":[171],"previous":[172],"non-responders":[173],"to":[174],"mostly":[177],"alcohol":[178,295],"abusers":[179],"(36.9%),":[180],"moderate":[182],"(13.3%),":[192],"psychotherapy":[194,280],"(15.9%)":[195],"(8.8%).":[201],"Discriminant":[202],"analysis":[203],"correctly":[204],"predicted":[205],"outcome":[206],"93.5%":[208],"patients.":[211],"Alcohol":[212],"abuse":[213,296],"by":[215],"far":[216],"strongest":[218],"predictor":[219],"negative":[221],"outcome.":[222,260],"Coexisting":[223],"anxiety":[225,239],"disorder":[226,254],"dysthymia":[228],"less":[230],"potent":[231],"regard,":[234],"whereas":[235],"baseline":[237],"Hamilton":[238],"depression":[241],"scale":[242],"scores,":[243],"phobia,":[246],"unassociated":[250],"avoidant":[252],"personality":[253],"predictors":[256],"positive":[259],"conclusion,":[262],"can":[266],"be":[267],"successfully":[268],"treated":[269],"but":[273],"many":[274,282],"may":[276],"need":[277],"medication":[278],"years.":[283],"Treatment":[284],"should":[285],"start":[286],"as":[287,289,294],"early":[288],"possible":[290],"because":[291],"complications":[292],"such":[293],"make":[297],"difficult.":[299]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2010198608","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
